Recent Finacing
Recent Raise
Encycle Therapeutics is a spin‑off drug discovery company developing the nacellin chemistry to create membrane‑permeable, orally bioavailable scaffolds targeting protein–protein interactions, advancing an oral integrin α4β7 inhibitor for IBD.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors